Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Andrew Sharf"'
Autor:
Jonathan S. Serody, Yunro Chung, Paul M. Armistead, Benjamin G. Vincent, Anastasia Ivanova, Kamakshi V. Rao, Jessica M. Davis, James M. Coghill, Jonathan R. Ptachcinski, Marcie L. Riches, Maurice Alexander, Katarzyna Jamieson, J. Ryan Shaw, Andrew Sharf, William A. Wood, Thomas C. Shea
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:391-397
Targeted busulfan dosing helps limit chemotherapy-related toxicity and optimize disease outcomes in hematopoietic stem cell transplantation (HCT). The objective of this study was to evaluate busulfan exposure from a pharmacokinetic (PK)-guided dosing
Autor:
Thomas C. Shea, Amber N Essenmacher, Paul Brown, Andrew Sharf, William A. Wood, Kamakshi V. Rao, Jonathan S. Serody, James M. Coghill, Robert Irons, Paul M. Armistead, Julia Whitley, Stefanie Sarantopoulos, Ravi K. Goyal, D. A. Gabriel
Publikováno v:
Bone Marrow Transplantation. 48:771-776
The effectiveness of stem cell mobilization with G-CSF in lymphoma patients is suboptimal. We reviewed our institutional experience using chemomobilization with etoposide (VP-16; 375 mg/m2 on days +1 and +2) and G-CSF (5 μg/kg twice daily from day +
Autor:
James M. Coghill, Dominic T. Moore, Marcie L. Riches, Kimberly A. Kasow, Benjamin G. Vincent, Jonathan S. Serody, Andrew Sharf, William A. Wood, Thomas C. Shea, Anureet C. Copeland, Paul M. Armistead, Katarzyna Jamieson
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S222-S223
Autor:
Julia Whitley, Andrew Sharf, William A. Wood, Thomas B. Shea, Jonathan S. Serody, D. A. Gabriel, Allison M. Deal
Publikováno v:
Pediatric Blood & Cancer. 57:499-505
Background The HCT-CI helps to predict non-relapse mortality (NRM) and overall survival (OS) in allogeneic hematopoietic cell transplantation (HCT) recipients. The usefulness of this index in a younger, adolescent and young adult (AYA) population is
Autor:
Dominic T. Moore, Jonathan S. Serody, Anne W. Beaven, Andrew Sharf, Thomas C. Shea, Don A. Gabriel
Publikováno v:
Cancer Investigation. 29:214-219
This study combined infusional mitoxantrone with bolus melphalan as a transplant preparative regimen for multiple myeloma. Mitoxantrone was infused over 6 hr on days 6 and 5. Melphalan was given as a 15 min bolus on day 1 followed by autologous trans
Autor:
Marcie L. Riches, Maurice Alexander, Deborah Covington, S. Elizabeth Sharf, Kimberly A. Kasow, Paul M. Armistead, Andrew Sharf, Thomas C. Shea
Publikováno v:
Biology of Blood and Marrow Transplantation. 24:S128
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S227
Autor:
Charlotte Haithcox, Paula Stinson, Rebecca Davis, S. Elizabeth Sharf, Megan McElfresh, Andrew Sharf, Alison Amos, Kinley Taylor, Marcie L. Riches
Publikováno v:
Biology of Blood and Marrow Transplantation. 23:S447
Autor:
Stephanie J. Lee, Sharmistha Rudra, Philip A. Roehrs, Jessica L. Allen, David A. Rizzieri, Madan Jagasia, Allison M. Deal, Nelson J. Chao, Jonathan S. Serody, Prasanthi V. Tata, Stefanie Sarantopoulos, Matthew S. Fore, Kristy L. Richards, Mitchell E. Horwitz, Jenna Wooten, Todd Hoffert, Andrew Sharf, Thomas C. Shea
Although B cells have emerged as important contributors to chronic graft-versus-host-disease (cGVHD) pathogenesis, the mechanisms responsible for their sustained activation remain unknown. We previously showed that patients with cGVHD have significan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84da9ac5ec3af88d2be200debebfb17b
https://europepmc.org/articles/PMC3968393/
https://europepmc.org/articles/PMC3968393/
Publikováno v:
Biology of Blood and Marrow Transplantation. 19(2)